Zofran
Psychosis Not Otherwise Specified
Pakistan Institute of Living and LearningPhase 2Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Psychosis Not Otherwise Specified cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
SIMVASTATIN Pakistan Institute of Living and Learning | Phase 2 | BB |
Same molecule, other indications
Zofran is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →